10 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DIAZYME LIQUID STABLE ENZYMATIC SODIUM ASSAY, MODEL DZ114B

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

SORIN BIOMEDICA SMART BCD VANGUARD,SURFACE MODIFIED BLOOD CARDIOPLEGIA SYSTEM

FDA 510(k)
FDA Class 2 ·Cardiovascular

REMREST

FDA 510(k)
FDA Class 2 ·Anesthesiology

RADIFOCUS OPTITORQUE

FDA Adverse Event
Malfunction ·TERUMO CORPORATION, ASHITAKA·Product code DQX·June 13, 2022

ACUITY

FDA Adverse Event
Injury ·CPI - DEL CARIBE·Product code OJX·April 29, 2013

LUMAX 340 VR-T

FDA Adverse Event
Malfunction ·BIOTRONIK SE & CO. KG·Product code MRM·April 29, 2011

4 MOTOR ADVANCE BED

FDA Adverse Event
Malfunction ·HILL-ROM RITTER·Product code FNL·July 23, 2008

HEARTMATE 3 TUNNELING LANCE AND HANDLE

FDA Adverse Event
Malfunction ·THORATEC CORPORATION·Product code DSQ·December 13, 2024

On-Board Imager - Exact Arm Elbow Motor Shaft (kVD, kVS, and MV) with ''Type 01" elbow motors. Product Usage: The On-Board Imager device is an x-ray device used for evaluation of correct patient position in relation to isocenter and verification of treatment fields in relation to anatomical and fiducial landmarks.

FDA Enforcement
Class II ·Terminated·Varian Medical Systems, Inc.·April 30, 2014

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012